Paloma Partners Management Co - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 176 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paloma Partners Management Co ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$346,000
-31.8%
13,625
-91.5%
0.01%0.0%
Q2 2017$507,000
-6.8%
160,0000.0%0.01%
-14.3%
Q1 2017$544,000
+76.6%
160,000
+49.7%
0.01%
+133.3%
Q4 2016$308,000
+68.3%
106,869
+75.3%
0.00%
+50.0%
Q2 2016$183,00060,9790.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders